Sustained Immunity: The Enduring Legacy of mRNA Vaccines

New research indicates that mRNA COVID-19 vaccines provide lasting protection, wiht immune responses persisting for at least three years. The study, conducted in Catalonia and published in Cell Reports, followed 113 healthcare workers who received three doses of an mRNA vaccine. The findings highlight the critical role of B-memory cells in maintaining long-term immunity.

As of early 2025, while COVID-19 case numbers fluctuate, understanding the durability of vaccine-induced immunity remains crucial. This study offers valuable insights into the long-term effectiveness of mRNA vaccines.

B-Memory Cells: The key to Long-Term Protection

B-memory cells are essential for a robust and lasting immune response.These cells rapidly multiply upon encountering an antigen, differentiating into antibody-secreting cells. This mechanism ensures that the body can quickly mount a defense against future infections.

There is a belief that the antibodies induced by the vaccine for SARS-COV-2 disappear quickly, but recent evidence suggests that they remain quite stable.

Gemma Moncunill,Isglobal

Study Details: Evaluating Antibody and B-Cell Durability

The research,part of the european End-Voc project,assessed the durability and quality of antibodies and B-memory cells in a cohort of healthcare workers (Covidcatral) over a three-year period. Participants, nonetheless of prior SARS-CoV-2 infection, developed comparable antibody and B-memory cell responses for approximately 18 months after receiving three mRNA vaccine doses.

Over time, I have noticed a progressive increase in the proportion of B-memory cells that recognize the field of receptor (RBD) of the Spike protein, which suggests their continuous selection when exposing to the evolved variants of the virus.

Luis Molinos-Albert,Lead Author

The Impact of Prior Infection: A Fingerprint on Immunity

The study revealed that prior SARS-CoV-2 infection leaves a distinct mark on the immune system. Individuals with prior exposure developed an atypical subset of B-memory cells that remained stable over time. The implications of this difference are still under investigation.

This is probably due to the different environment generated by the primary vaccination MRNA compared to the viral infection. Though, we do not know if this subset of B-memory cells is harmful or beneficial.

Carlota Dobaño

IgG4 Antibodies and Breakthrough Infections: A Complex Relationship

another study using the same cohort,published in the Journal of Infection,found an increase in IgG4 antibodies after three mRNA vaccine doses. Higher levels of IgG4 and IgG2 antibodies, which have a reduced ability to neutralize the virus, were associated with a greater risk of breakthrough infections. this suggests a complex interplay between antibody subclasses and infection risk.

Implications for Future Vaccination Strategies

The research underscores the long-term protection offered by COVID-19 vaccines, even more than a year after the initial three-dose series. Both previously infected and uninfected individuals developed effective immune responses. Furthermore, the study suggests that updated vaccines targeting new variants could further enhance immunity, particularly for those with prior infections.

Our data emphasize the durability of immunological responses to SARS-COV-2, but also suggests that the updated vaccines for new variants could improve even more immunity, especially to those who have been infected previously.

Gemma Moncunill